Document:

Exhibit 10.2

 

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this
“Agreement”), dated as of [_], 2022, is made and entered into by and among [_] (the
“Company”), Larkspur Health Acquisition Corp., a Delaware corporation (the
“SPAC”), Larkspur Health LLC, a Delaware limited liability company (the
“Sponsor”), certain initial investors comprised of [INSERT NAME(S)] (“[_]”) (such investors
collectively with the Sponsor, the “Initial Investors”), [INSERT NAME] (“the
“Representative”), and the undersigned parties listed under Holders on the signature page hereto (each
such party, together with the Initial Investors and any other parties listed on the signature pages hereto and any person or entity
who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, being referred to herein as a
“Holder” and collectively as the “Holders”).

 

RECITALS

 

WHEREAS,
the Company, the SPAC, and Larkspur Merger Sub, Inc. a Delaware corporation (“Merger Sub”) are parties to that
certain Business Combination Agreement dated as of the date hereof (as such agreement may be amended, supplemented, restated or otherwise
modified from time to time (the “Business Combination Agreement”), pursuant to which (and subject to the terms
and conditions set forth therein) inter alia, Merger Sub will be merged with and into the Company, with the Company surviving the
Merger as a wholly-owned subsidiary of the SPAC;

 

WHEREAS,
the Initial Investors and the SPAC entered into that certain Registration Rights Agreement dated December 20, 2021 (as such agreement
may be amended, supplemented, restated or otherwise modified from time to time until the consummation of the Business Combination, the
“Existing Agreement”); and

 

WHEREAS,
upon consummation of the Business Combination, each party to the Existing Agreement desires to amend and restate the Existing Agreement
in its entirety as set forth herein and the Company and the Holders desire to enter into this Agreement, pursuant to which the Company
shall grant the Holders certain registration rights with respect to the Registrable Securities (as defined below) on the terms and conditions
set forth in this Agreement.

 

NOW,
THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby
agree as follows:

 

ARTICLE
I 

DEFINITIONS

 

1.1 Definitions.
The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

 

“Adverse
Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith
judgment of the Chief Executive Officer or principal financial officer of the Company, after consultation with counsel to the
Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration
Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements contained therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances
under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were
not being filed, and (iii) the Company has a bona fide business purpose for not making such information public.
“Agreement” shall have the meaning given in the Preamble.

 

“Board” shall mean the Board
of Directors of the Company.

 

“Business
Combination” shall mean any merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar
business combination with one or more businesses or entities, involving the Company.

 

“Commission” shall mean the Securities
and Exchange Commission.

 

     

     

    

 

“Company” shall have the meaning
given in the Preamble.

 

“Company Common Stock”
shall mean the Company’s common stock, par value $0.00001 per share.

 

“Demand Registration” shall have
the meaning given in subsection 2.1.1.

 

“Demanding Holder” shall have the
meaning given in subsection 2.1.1.

 

“Exchange Act” shall mean the
Securities Exchange Act of 1934, as it may be amended from time to time. “Form S-1” shall have the meaning given
in subsection 2.1.1.

 

“Form S-3” shall have the meaning
given in subsection 2.3.

 

“Founder
Shares” shall mean the aggregate of [●] shares of the SPAC Class B Common
Stock (as defined below) issued to the Sponsor prior to the SPAC’s initially public offering, including: (a) the sale of 2,156,250
Founds Shares by the SPAC on May 7, 2021 to the following Holders for an aggregate purchase price of $25,000, or approximately $0.012
per share: (i) 1,494,998 Founder Shares to the Sponsor; (ii) 632,500 Founder Shares to the Representative (the “Representative
Shares”); (iii) 9,584 Founder Shares to Raj Mehra; (iv) 9,584 Founder Shares to Christopher Twitty; and (v) 9,584 Founder
Shares to Gregory Skalicky; (b) the 21,777 Founder Shares forfeited by the Represented on September 11, 2021 for no consideration; (c)
the transfer of (i) 231,423 Founder Shares by the Sponsor on [●], 2021, (ii) 110,723
Founder Shares by the Representative on [●], 2021, and (iii) 21,777 Founder Shares reissued
to the Initial Investors on November 4, 2021; (d) up to 281,250 Founder Shares forfeited by the Holders (including up to 60,723 Founder
Shares forfeited by the Representative) depending on the extent to which the underwriters of the SPAC’s initial public offering
exercise their over-allotment option; and (e) the transfer of an additional 4,494 Founder Shares by the Representative to the Initial
Investors if the underwriters’ over-allotment option is not exercised. The Founder Shares shall be deemed to include the shares
of SPAC Common Stock issuable upon conversion thereof.

 

“Founder
Shares Lock-up Period” shall mean, with respect to the Founder Shares, the period ending on the earlier of (A) 180 days
after the completion of the initial Business Combination and (B) subsequent to the Business Combination, (x) if the reported last sale
price of the Company Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 90 days after the initial
Business Combination or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other
similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Company Common
Stock for cash, securities or other property. Notwithstanding the foregoing, the Initial Investors shall have the right to transfer their
ownership in the Founder Shares at any time to the extent that they determine, in good faith, that such transfer is necessary to ensure
that they and/or any of their parents, subsidiaries or affiliates are in compliance with the Investment Company Act of 1940.

 

“Holders” shall have the meaning
given in the Preamble.

 

“Insider
Letter” shall mean that certain letter agreement, dated as of [ ], 2021, by and among the SPAC, the Initial Investors, the
Representative and each of the SPAC’s officers, directors, director nominees and advisors.

 

“Maximum Number of Securities”
shall have the meaning given in subsection 2.1.4.

 

“Misstatement”
shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the light of the circumstances under
which they were made) not misleading.

 

“Permitted
Transferees” shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable
Securities prior to the expiration of the Founder Shares Lock-up Period, under the Insider Letter, this Agreement and
any other applicable agreement between such Holder and the SPAC and/or the Company, and to any transferee thereafter.

 

    2

     

    

 

“Piggyback Registration” shall have
the meaning given in subsection 2.2.1.

 

“Pro Rata” shall have the meaning
given in subsection 2.1.4.

 

“Prospectus”
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

 

“Registrable
Security” shall mean (a) the shares of the Company Common Stock and other equity securities convertible or exercisable
or exchangeable for shares of the Company Common Stock held by the Holders, and the shares of Company Common Stock underlying such
equity securities, including (a) the Founder Shares and the shares of SPAC Common Stock issued or issuable upon the conversion of
any Founder Shares, (b) the Representative Shares (including the shares of SPAC Common Stock issued or issuable upon conversion of
the Representative Shares), (c) any outstanding shares of the SPAC Common Stock or any other equity security (including the shares
of SPAC Common Stock issued or issuable upon the exercise of any other equity security) of the SPAC held by a Holder as of the date
of this Agreement, (d) the Private Warrants, and (e) any other equity security of the SPAC issued or issuable with respect to any
such share of the SPAC Common Stock by way of a stock dividend or stock split or in connection with a combination of shares,
recapitalization, merger, consolidation or reorganization; provided, however, that, as to any particular Registrable
Security, such securities shall cease to be Registrable Securities when: (A) a Registration Statement with respect to the sale of
such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed
of or exchanged in accordance with such Registration Statement; (B) such securities shall have been otherwise transferred, new
certificates for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and
subsequent public distribution of such securities shall not require registration under the Securities Act; (C) such securities shall
have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 promulgated under the
Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or
limitations); or (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or
other public securities transaction.

 

“Registration”
shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

 

“Registration
Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:

 

(A) 
all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory
Authority, Inc.) and any securities exchange on which the Company Common Stock is then listed;

 

(B) fees
and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the
Underwriters in connection with blue sky qualifications of Registrable Securities);

 

(C)
printing, messenger, telephone and delivery expenses;

 

(D)
reasonable fees and disbursements of counsel for the Company;

 

(E)
reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection
with such Registration; and

 

(F)
reasonable fees and expenses of one (1) legal counsel selected by the majority-in-interest of the Demanding Holders initiating
a Demand Registration to be registered for offer and sale in the applicable Registration.

 

    3

     

    

 

“Registration
Statement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this
Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements
to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

 

“Requesting Holder” shall have
the meaning given in subsection 2.1.1.

 

“Representative” shall have
the meaning given in the Recitals hereto.

 

“Representative Shares Lock-up
Period” shall mean, with respect to the Representative Shares that are held by the Representative, the period ending 180
days after the effective date of the Registration Statement.

 

“Securities Act” shall mean the
Securities Act of 1933, as amended from time to time.

 

“SPAC Common Stock” shall mean
the SPAC’s Class A common stock, par value $0.0001 per share.

 

“SPAC Class B Common
Stock” shall mean the SPAC’s Class B common stock, par value $0.0001 per share.

 

“Sponsor” shall have the meaning
given in the Preamble hereto.

 

“Private
Unit Purchase Agreements” shall mean those certain Private Unit Purchase Agreements entered into by and between the SPAC
and the Initial Investors dated as of [●], pursuant to which the Initial Investors agreed to purchase an aggregate of 317,600 units
(or 328,850 units if the underwriters’ over-allotment option is exercised) of the Company (“Private Units”),
each Private Unit comprised of one share of the SPAC Common Stock, and three- fourths of one warrant to purchase one share of the SPAC
Common Stock (“Private Warrant”), for an aggregate purchase price of $3,176,000 (or $3,288,500 if the underwriters’
over-allotment option is exercised), or $10.00 per Private Unit, in private placement transactions occurring simultaneously with the
closing of the SPAC’s initial public offering.

 

“Underwriter”
shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such
dealer’s market-making activities.

 

“Underwritten
Registration” or “Underwritten Offering” shall mean a Registration in which securities of the
Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

 

ARTICLE
II

 REGISTRATIONS

 

2.1 
Demand Registration.

 

2.1.1 Request
for Registration. Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, at any time and from time
to time on or after the date that is one hundred and eighty (180) days from the date hereof, the Holders of at least a majority in
interest of the then-outstanding number of Registrable Securities (the “Demanding Holders”) may make a
written demand for Registration of all or part of their Registrable Securities, which written demand shall describe the amount and
type of securities to be included in such Registration and the intended method(s) of distribution thereof (such written demand a
“Demand Registration”). The Company shall, within ten (10) days of the Company’s receipt of the
Demand Registration, notify, in writing, all other Holders of Registrable Securities of such demand, and each Holder of Registrable
Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in a Registration
pursuant to a Demand Registration (each such Holder that includes all or a portion of such Holder’s Registrable Securities in
such Registration, a “Requesting Holder”) shall so notify the Company, in writing, within five (5) days
after the receipt by the Holder of the notice from the Company. Upon receipt by the Company of any such written notification from a
Requesting Holder(s) to the Company, such Requesting Holder(s) shall be entitled to have their Registrable Securities included in a
Registration pursuant to a Demand Registration and the Company shall effect, as soon thereafter as practicable, but not more than
forty five (45) days immediately after the Company’s receipt of the Demand Registration, the Registration of all Registrable
Securities requested by the Demanding Holders and Requesting Holders pursuant to such Demand Registration. Under no circumstances shall the Company
be obligated to effect more than an aggregate of two (2) Registrations pursuant to a Demand Registration under this subsection 2.1.1
with respect to any or all Registrable Securities; provided, however, that a Registration shall not be counted for such
purposes unless a Form S-1 or any similar long-form registration statement that may be available at such time (“Form S-1”)
has become effective and all of the Registrable Securities requested by the Requesting Holders to be registered on behalf of the Requesting
Holders in such Form S-1 Registration have been sold, in accordance with Section 3.1 of this Agreement.

 

    4

     

    

 

2.1.2  Effective
Registration. Notwithstanding the provisions of subsection 2.1.1 above or any other part of this Agreement, at any time
and from time to time on or after the date that is one hundred and eighty (180) days from the date hereof, a Registration pursuant
to a Demand Registration shall not count as a Registration unless and until (i) the Registration Statement filed with the Commission
with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and (ii) the Company
has complied with all of its obligations under this Agreement with respect thereto; provided, further, that if, after
such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to a
Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any
other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared
effective, unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a
majority-in-interest of the Demanding Holders initiating such Demand Registration thereafter affirmatively elect to continue with
such Registration and accordingly notify the Company in writing, but in no event later than five (5)  days,
of such election; and provided, further, that the Company shall not be obligated or required to file another
Registration Statement until the Registration Statement that has been previously filed with respect to a Registration pursuant to a
Demand Registration becomes effective or is subsequently terminated.

 

2.1.3
Underwritten Offering. Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, if a majority-in-interest
of the Demanding Holders so advise the Company as part of their Demand Registration that the offering of the Registrable Securities pursuant
to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder
(if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such
Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such Underwritten Offering to the extent provided
herein. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection
2.1.3 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering
by the majority-in-interest of the Demanding Holders initiating the Demand Registration, which such Underwriter(s) shall be reasonably
acceptable to the Company.

 

2.1.4
Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Registration pursuant
to a Demand Registration, in good faith, advises the Company, the Demanding Holders and the Requesting Holders (if any) in writing that
the dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken
together with all other Common Stock or other equity securities that the Company desires to sell and the Company Common Stock, if any,
as to which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by any other
stockholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten
Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of
such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”),
then the Company shall include in such Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders
and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each Demanding Holder and
Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities
that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred
to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number of Securities; (ii) second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Registrable Securities of
Holders (Pro Rata, based on the respective number of Registrable Securities that each Holder has so requested) exercising their rights
to register their Registrable Securities pursuant to subsection 2.2.1 hereof, without exceeding the Maximum Number of Securities;
and (iii) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the
Company Common Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number
of Securities; and (iv) fourth, to the extent that the Maximum Number of Securities has not been reached under the
foregoing clauses (i), (ii) and (iii), the Company Common Stock or other equity securities of other persons or entities that the Company
is obligated to register in a Registration pursuant to separate written contractual arrangements with such persons and that can be sold
without exceeding the Maximum Number of Securities.

 

    5

     

    

 

2.1.5
Demand Registration Withdrawal. A majority-in-interest of the Demanding Holders initiating a Demand Registration or a majority-in-interest
of the Requesting Holders (if any), pursuant to a Registration under subsection 2.1.1 shall have the right to withdraw from a Registration
pursuant to such Demand Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters
(if any) of their intention to withdraw from such Registration prior to the effectiveness of the Registration Statement filed with the
Commission with respect to the Registration of their Registrable Securities pursuant to such Demand Registration. Notwithstanding anything
to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Registration
pursuant to a Demand Registration prior to its withdrawal under this subsection 2.1.5.

 

2.2
Piggyback Registration.

 

2.2.1
Piggyback Rights. If, at any time on or after the date the Company consummates a Business Combination, the Company proposes
to file a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations
exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of stockholders of the
Company (or by the Company and by the stockholders of the Company including, without limitation, pursuant to Section 2.1 hereof),
other than a Registration Statement (i) filed in connection with any employee stock option or other benefit plan, (ii) for an exchange
offer or offering of securities solely to the Company’s existing stockholders, (iii) for an offering of debt that is convertible
into equity securities of the Company or (iv) for a dividend reinvestment plan, then the Company shall give written notice of such proposed
filing to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated filing
date of such Registration Statement, which notice shall (A) describe the amount and type of securities to be included in such offering,
the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and
(B) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities
as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration a “Piggyback
Registration”). The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration
and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable
Securities requested by the Holders pursuant to this subsection 2.2.1 to be included in a Piggyback Registration on the same terms
and conditions as any similar securities of the Company included in such Registration and to permit the sale or other disposition of such
Registrable Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their
Registrable Securities through an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement
in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company.

 

2.2.2
Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Registration that is
to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback
Registration in writing that the dollar amount or number of the shares of Company Common Stock that the Company desires to sell, taken
together with (i) the shares of Company Common Stock, if any, as to which Registration has been demanded pursuant to separate written
contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder (ii) the Registrable Securities
as to which registration has been requested pursuant to Section 2.2 hereof, and (iii) the shares of Company Common Stock, if any,
as to which Registration has been requested pursuant to separate written contractual piggy- back registration rights of other stockholders
of the Company, exceeds the Maximum Number of Securities, then:

 

(a) 
If the Registration is undertaken for the Company’s account, the Company shall include in any such Registration (A) first,
the Company Common Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum
Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause
(A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection
2.2.1 hereof, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the
Maximum Number of Securities has not been reached
under the foregoing clauses (A) and (B), the Company Common Stock, if any, as to which Registration has been requested pursuant to written
contractual piggy-back registration rights of other stockholders of the Company, which can be sold without exceeding the Maximum Number
of Securities;

 

    6

     

    

 

(b)
If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the
Company shall include in any such Registration (A) first, the Company Common Stock or other equity securities, if any, of such requesting
persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities;
(B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities
of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1, pro rata based on the
number of Registrable Securities that each Holder has requested be included in such Underwritten Registration and the aggregate number
of Registrable Securities that the Holders have requested to be included in such Underwritten Registration, which can be sold without
exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under
the foregoing clauses (A) and (B), the Company Common Stock or other equity securities that the Company desires to sell, which can be
sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been
reached under the foregoing clauses (A), (B) and (C), the Company Common Stock or other equity securities for the account of other persons
or entities that the Company is obligated to register pursuant to separate written contractual arrangements with such persons or entities,
which can be sold without exceeding the Maximum Number of Securities.

 

2.2.3
Piggyback Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback
Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of
his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed
with the Commission with respect to such Piggyback Registration. The Company (whether on its own good faith determination or as the result
of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed
with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement.
Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in
connection with the Piggyback Registration prior to its withdrawal under this subsection 2.2.3.

 

2.2.4
Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.2
hereof shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1 hereof.

 

2.3 
Registrations on Form S-3. Any Holder of Registrable Securities may at any time, and from time to time, request in writing
that the Company, pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register
the resale of any or all of their Registrable Securities on Form S-3 or any similar short form registration statement that may be available
at such time (“Form S-3”); provided, however, that the Company shall not be obligated to effect
such request through an Underwritten Offering. Within five (5) days of the Company’s receipt of a written request from a Holder
or Holders of Registrable Securities for a Registration on Form S-3, the Company shall promptly give written notice of the proposed Registration
on Form S-3 to all other Holders of Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include
all or a portion of such Holder’s Registrable Securities in such Registration on Form S-3 shall so notify the Company, in writing,
within ten (10) days after the receipt by the Holder of the notice from the Company. As soon as practicable thereafter, but not more than
twelve (12) days after the Company’s initial receipt of such written request for a Registration on Form S-3, the Company shall register
all or such portion of such Holder’s Registrable Securities as are specified in such written request, together with all or such
portion of Registrable Securities of any other Holder or Holders joining in such request as are specified in the written notification
given by such Holder or Holders; provided, however, that the Company shall not be obligated to effect any such Registration
pursuant to Section 2.3 hereof if (i) a Form S-3 is not available for such offering; or (ii) the Holders of Registrable Securities,
together with the Holders of any other equity securities of the Company entitled to inclusion in such Registration, propose to sell the
Registrable Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000.

 

    7

     

    

 

2.4 
Restrictions on Registration Rights. If (A) during the period starting with the date sixty (60) days prior to the Company’s
good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of,
a Company initiated Registration and provided that the Company has delivered written notice to the Holders prior to receipt of a Demand
Registration pursuant to subsection 2.1.1 and it continues to actively employ, in good faith, all reasonable efforts to cause the
applicable Registration Statement to become effective; (B) the Holders have requested an Underwritten Registration and the Company and
the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C) in the good faith judgment of the
Board such Registration would be seriously detrimental to the Company and the Board concludes as a result that it is essential to defer
the filing of such Registration Statement at such time, then in each case the Company shall furnish to such Holders a certificate signed
by the Chairman of the Board stating that in the good faith judgment of the Board it would be seriously detrimental to the Company for
such Registration Statement to be filed in the near future and that it is therefore essential to defer the filing of such Registration
Statement. In such event, the Company shall have the right to defer such filing for a period of not more than thirty (30) days; provided,
however, that the Company shall not defer its obligation in this manner more than once in any 12-month period.

 

ARTICLE III 

COMPANY PROCEDURES

 

3.1
General Procedures. If at any time on or after the date the Company consummates a Business Combination the Company is required
to effect the Registration of Registrable Securities, the Company shall use its best efforts to effect such Registration to permit the
sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall,
as expeditiously as possible:

 

3.1.1 
prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities
and use its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable
Securities covered by such Registration Statement have been sold;

 

3.1.2
prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements
to the Prospectus, as may be requested by any Holder or any Underwriter of Registrable Securities or as may be required by the rules,
regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations
thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold
in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;

 

3.1.3
prior to filing a Registration Statement or prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters,
if any, and each Holder of Registrable Securities included in such Registration, and each such Holder’s legal counsel, copies of
such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including
all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including
each preliminary Prospectus), and such other documents as the Underwriters and each Holder of Registrable Securities included in such
Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities
owned by such Holders;

 

3.1.4
prior to any public offering of Registrable Securities, use its best efforts to (i) register or qualify the Registrable Securities
covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States
as any Holder of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may
request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered
with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and
do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such
Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however,
that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required
to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it
is not then otherwise so subject;

 

    8

     

    

 

3.1.5
cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities
issued by the Company are then listed;

 

3.1.6
provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective
date of such Registration Statement;

 

3.1.7
advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance
of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any
proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal
if such stop order should be issued;

 

3.1.8
at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration
Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus, furnish
a copy thereof to each seller of such Registrable Securities and its counsel, including, without limitation, providing copies promptly
upon receipt of any comment letters received with respect to any such Registration Statement or Prospectus;

 

3.1.9 
notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the
Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in
effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;

 

3.1.10
permit a representative of the Holders (such representative to be selected by a majority of the participating Holders), the Underwriters,
if any, and any attorney or accountant retained by such Holders or Underwriter to participate, at each such person’s own expense,
in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees to supply all information
reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided,
however, that such representatives or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory
to the Company, prior to the release or disclosure of any such information; and provided further, the Company may not include the
name of any Holder or Underwriter or any information regarding any Holder or Underwriter in any Registration Statement or Prospectus,
any amendment or supplement to such Registration Statement or Prospectus, any document that is to be incorporated by reference into such
Registration Statement or Prospectus, or any response to any comment letter, without the prior written consent of such Holder or Underwriter
and providing each such Holder or Underwriter a reasonable amount of time to review and comment on such applicable document, which comments
the Company shall include unless contrary to applicable law;

 

3.1.11 
obtain a “cold comfort” letter from the Company’s independent registered public accountants in the event of an
Underwritten Registration which the participating Holders may rely on, in customary form and covering such matters of the type customarily
covered by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest
of the participating Holders;

 

3.1.12 
on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date,
of counsel representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent,
if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is
being given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such
opinions and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;

 

3.1.13
in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing Underwriter of such offering;

 

3.1.14
make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least
twelve (12) months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration
Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule
promulgated thereafter by the Commission); provided that the Company will be deemed to have satisfied such requirement
to the extent such information is filed on the Commission’s EDGAR or any successor system.

 

    9

     

    

 

3.1.15 
if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use
its commercially reasonable efforts to make available senior executives of the Company to participate in customary “road show”
presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and

 

3.1.16
otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders,
in connection with such Registration.

 

3.2 
Registration Expenses. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged
by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’
commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration
Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders.

 

3.3 
Requirements for Participation in Underwritten Offerings. No person may participate in any Underwritten Offering for equity
securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person (i) agrees to sell such person’s
securities on the basis provided in any underwriting arrangements approved by the Company and (ii) completes and executes all customary
questionnaires, powers of attorney, indemnities, lock- up agreements, underwriting agreements and other customary documents as may be
reasonably required under the terms of such underwriting arrangements.

 

3.4
Suspension of Sales; Adverse Disclosure. Upon receipt of written notice from the Company that a Registration Statement or
Prospectus contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until he, she
or it has received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby
covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until he, she or
it is advised in writing by the Company that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued
use of a Registration Statement in respect of any Registration at any time would require the Company to make an Adverse Disclosure or
would require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond
the Company’s control, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial
effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, but in no event more than thirty (30)
days, determined in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under the
preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus
relating to any Registration in connection with any sale or offer to sell Registrable Securities. The Company shall immediately notify
the Holders of the expiration of any period during which it exercised its rights under this Section 3.4.

 

3.5 
Reporting Obligations. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall
be a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d)
of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings. The Company further covenants
that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such
Holder to sell shares of the Company Common Stock held by such Holder without registration under the Securities Act within the limitation
of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission),
including providing any legal opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written certification
of a duly authorized officer as to whether it has complied with such requirements.

 

3.6
Limitations on Registration Rights. Notwithstanding anything herein to the contrary, (i) the Representative may not exercise
its rights under Sections 2.1 and 2.2 hereunder after five (5) and seven (7) years after the effective date of the registration statement relating
to the Business Combination, respectively, and (ii) the Representative may not exercise its rights under Section 2.1 more than one time.

 

    10

     

    

 

ARTICLE IV

 INDEMNIFICATION
AND CONTRIBUTION

 

4.1
Indemnification.

 

4.1.1
The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors
and each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and
expenses (including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact contained in any Registration
Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of
a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are
caused by or contained in any information furnished in writing to the Company by such Holder expressly for use therein. The Company shall
indemnify the Underwriters, their officers and directors and each person who controls such Underwriters (within the meaning of the Securities
Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.

 

4.1.2
In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish
to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration
Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and officers and agents and each
person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses
(including without limitation reasonable attorneys’ fees) resulting from any untrue statement of material fact contained in the
Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material
fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue
statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein; provided,
however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities,
and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by
such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall
indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the Securities
Act) to the same extent as provided in the foregoing with respect to indemnification of the Company.

 

4.1.3
Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to
indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified
party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such
claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party.
If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party
without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not
to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel (plus local counsel) for
all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party
a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim.
No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement
which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms
of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
indemnified party of a release from all liability in respect to such claim or litigation.

 

4.1.4
The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made
by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party
and shall survive the transfer of securities. The Company and each Holder of Registrable Securities participating in an offering also
agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company’s
or such Holder’s indemnification is unavailable for any reason.

 

    11

     

    

 

4.1.5 
If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold
harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying
party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result
of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying
party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or
alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information
supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent,
knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability
of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such Holder in such offering
giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to above
shall be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3 above, any
legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties
hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined by pro rata
allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this subsection
4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent misrepresentation.

 

ARTICLE V 

MISCELLANEOUS

 

5.1 
Notices. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States
mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery
in person or by courier service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail, telecopy, telegram
or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently
given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and,
in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time as
it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the
addressee upon presentation. Any notice or communication under this Agreement must be addressed, if to the Company, to: 2200 N. Commerce
Parkway, Suite 208, Weston, FL 33326, Attention: Stephen C. Glover, Chief Executive Officer, and, if to any Holder, at such Holder’s
address or contact information as set forth in the Company’s books and records. Any party may change its address for notice at any
time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30)
days after delivery of such notice as provided in this Section 5.1.

 

5.2
Assignment; No Third Party Beneficiaries.

 

5.2.1
This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company
in whole or in part.

 

5.2.2 
Prior to the expiration of the Founder Shares Lock-up Period or the Representative Shares Lock- up Period, as the case may be,
no Holder may assign or delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part, except in
connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only if such Permitted Transferee agrees
to become bound by the transfer restrictions set forth in this Agreement.

 

    12

     

    

 

5.2.3
This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors
and the permitted assigns of the Holders, which shall include Permitted Transferees.

 

5.2.4 
This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set
forth in this Agreement and Section 5.2 hereof.

 

5.2.5 
No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate
the Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section 5.1 hereof
and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions
of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made
other than as provided in this Section 5.2 shall be null and void.

 

5.3
Counterparts. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of
which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced.

 

5.4 
Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES
EXPRESSLY AGREE THAT (I) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS
AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF
SUCH JURISDICTION AND (II) THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK
COUNTY IN THE STATE OF NEW YORK.

 

5.5 
Amendments and Modifications. Upon the written consent of the Company and the Holders of at least a majority in interest
of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this
Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however,
that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its
capacity as a holder of the shares of capital stock of the Company, in a manner that is materially different from the other Holders (in
such capacity) shall require the consent of the Holder so affected. No course of dealing between any Holder or the Company and any other
party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement
shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies
under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder
by such party.

 

5.6 
Other Registration Rights. The Company represents and warrants that no person, other than a Holder of Registrable Securities,
has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in
any Registration filed by the Company for the sale of securities for its own account or for the account of any other person. Further,
the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms
and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement
shall prevail.

 

5.7
Term. This Agreement shall terminate upon the earlier of (i) the tenth anniversary of the date of this Agreement or (ii)
the date as of which (A) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior
to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated
thereafter by the Commission)) or (B) the Holders of all Registrable Securities are permitted to sell the Registrable Securities under
without registration pursuant to Rule 144 (or any similar provision) under the Securities Act without limitation on the amount of securities
sold or the manner of sale. The provisions of Section 3.5 and Article IV shall survive any termination.

 

[Signature Page Follows]

 

    13Exhibit 10.3

 

SHAREHOLDER
SUPPORT AGREEMENT

 

This
Support Agreement (this “Agreement”), dated as of July [  ], 2022, is entered into by and among Larkspur Health Acquisition
Corp., a Delaware corporation (“SPAC”), ZyVersa Therapeutics, Inc., a Florida corporation (the “Company”),
and certain of the stockholders of the Company, whose names appear on the signature pages of this Agreement (each a “Stockholder”,
and such stockholders collectively, the “Stockholders”, and SPAC, the Company and the Stockholders, each a “Party”,
and collectively, the “Parties”). Capitalized terms used but not otherwise defined in this Agreement shall have the
meanings ascribed to them in the Business Combination Agreement (the “Business Combination Agreement”) among SPAC,
Larkspur Merger Sub Inc., a Delaware corporation and wholly owned direct Subsidiary of the SPAC (“Merger Sub”), Stephen
Glover, in his capacity as the representative of the shareholders of the Company, and the Company.

 

RECITALS

 

WHEREAS,
concurrently herewith, the parties thereto are entering into the Business Combination Agreement, pursuant to which (and subject to the
terms and conditions set forth therein) Merger Sub will merge with and into the Company, with the Company surviving the Merger as a wholly
owned Subsidiary of the SPAC (the “Merger”);

 

WHEREAS,
as of the date hereof, each Stockholder is the record and “beneficial owner” (as such term is used herein, within the meaning
of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (together with the rules and regulations promulgated thereunder,
the “Exchange Act”)) of, and is entitled to dispose of and vote, the number of shares of Company Common Stock and
Company Preferred Stock set forth below such Stockholder’s name on such Stockholder’s counterpart signature page to this
Agreement (collectively, with respect to each Stockholder, such Stockholder’s “Owned Shares”; and such Owned
Shares, together with (1) any additional shares of Company Common Stock and Company Preferred Stock (or any securities convertible into
or exercisable or exchangeable for Company Common Stock or Company Preferred Stock) in which such Stockholder acquires record and beneficial
ownership after the date hereof, including by purchase, as a result of a stock dividend, stock split, recapitalization, combination,
reclassification, exchange or change of such shares, or upon exercise or conversion of any securities and (2) any additional shares of
Company Common Stock and Company Preferred Stock with respect to which such Stockholder has the right to vote through a proxy, the “Covered
Shares”); and

 

WHEREAS,
as a condition and inducement to the willingness of SPAC and Merger Sub to enter into the Business Combination Agreement, the Company
and the Stockholders are entering into this Agreement.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally
bound hereby, the Company, SPAC and each Stockholder hereby agree as follows:

 

1. Agreement
to Vote. Subject to the earlier termination of this Agreement in accordance with Section 3 and the last paragraph of this
Section 1, the Stockholder, solely in his, her or its capacity as a stockholder or proxy holder of the Company, irrevocably and
unconditionally agrees, and agrees to cause any other holder of record of any of the Stockholder’s Covered Shares, to validly execute
and deliver to the Company in respect of all of the Stockholder’s Covered Shares, on (and effective as of) the date that is the
second day following the date that the consent solicitation statement/prospectus included in the Registration Statement is disseminated
to the Company’s stockholders (following the effective date of the Registration Statement), a written consent in respect of all
of the Stockholder’s Covered Shares approving the Merger, the Business Combination Agreement, the other transactions contemplated
thereby and any other matters necessary or reasonably requested by the Company or SPAC in connection therewith. In addition, subject
to the last paragraph of this Section 1, prior to the Termination Date (as defined herein), the Stockholder, in his, her or its
capacity as a stockholder or proxy holder of the Company, irrevocably and unconditionally agrees that, at any other meeting of the stockholders
of the Company (whether annual or special and whether or not an adjourned or postponed meeting, however called and including any adjournment
or postponement thereof) and in connection with any written consent of stockholders of the Company, such Stockholder shall, and shall
cause any other holder of record of any of such Stockholder’s Covered Shares to:

 

(a) when
such meeting is held, appear at such meeting or otherwise cause the Stockholder’s Covered Shares to be counted as present thereat
for the purpose of establishing a quorum;

 

     

    

    

 

(b) vote
(or execute and return an action by written consent), or cause to be voted at such meeting (or validly execute and return and cause such
consent to be granted with respect to), all of such Stockholder’s Covered Shares owned as of the record date for such meeting (or
the date that any written consent is executed by such Stockholder) in favor of the Merger, the Business Combination Agreement, the other
transactions contemplated thereby and any other matters necessary or reasonably requested by the Company in connection with therewith;

 

(c) in
any other circumstances upon which a consent or other approval is required under the Company’s Organizational Documents or otherwise
sought with respect to the Merger, the Business Combination Agreement or the other transactions contemplated by the Business Combination
Agreement, vote, consent or approve (or cause to be voted, consented or approved) all of such Stockholder’s Covered Shares held
at such time in favor thereof; and

 

(d) vote
(or execute and return an action by written consent), or cause to be voted at such meeting (or validly cause such consent to be
granted with respect to), all of such Stockholder’s Covered Shares against (i) any Alternative Transaction (other than as
contemplated by the Business Combination Agreement); (ii) any proposal that would result in a change in the business, management or
the board of directors of the Company (other than as contemplated by the Business Combination Agreement); and (iii) any proposal,
action or agreement that would be reasonably expected to (A) impede, frustrate, prevent or nullify any provision of this Agreement,
the Business Combination Agreement or the Merger, (B) result in a breach in any respect of any covenant, representation, warranty or
any other obligation or agreement of the Company under the Business Combination Agreement, (C) result in any of the conditions set
forth in Article VIII of the Business Combination Agreement not being fulfilled or (D) change in any manner the dividend policy or
capitalization of, including the voting rights of any class of capital stock of, the Company.

 

The
obligations of each Stockholder specified in this Section 1 shall apply whether or not the Merger or any action described above
is recommended by the board of directors of the Company or the board of directors of the Company has previously recommended the Merger
but changed such recommendation.

 

2. No
Inconsistent Agreements. Each Stockholder hereby covenants and agrees that such Stockholder shall not (i) enter into any voting agreement
or voting trust with respect to any of such Stockholder’s Covered Shares that is inconsistent with such Stockholder’s obligations
pursuant to this Agreement, (ii) grant a proxy or power of attorney with respect to any of such Stockholder’s Covered Shares that
is inconsistent with such Stockholder’s obligations pursuant to this Agreement, or (iii) enter into any agreement or undertaking
that is otherwise inconsistent with, or would interfere with, or prohibit or prevent it from satisfying, its obligations pursuant to
this Agreement.

 

3. Termination.
This Agreement shall terminate upon the earliest of (i) the Effective Time, (ii) the termination of the Business Combination
Agreement in accordance with its terms, (iii) the adoption by the SPAC and the Company of any material amendment to the Business
Combination Agreement and (iv) the time this Agreement is terminated upon the written agreement of the Company, SPAC and the
Stockholder (the earliest such date under clause (i), (ii) and (iii) being referred to herein as the “Termination
Date”) and the representations, warranties, covenants and agreements contained in this Agreement and in any certificate or
other writing delivered pursuant hereto shall not survive the Closing or the termination of this Agreement; provided, that
the provisions set forth in Sections 10 through 21 shall survive the termination of this Agreement.

 

4. Representations
and Warranties of the Stockholders. Each Stockholder hereby represents and warrants (severally and not jointly as to itself only)
to the SPAC as follows:

 

(a) Such
Stockholder is the sole beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of, and has good, valid and marketable
title to or has a valid proxy to vote such shares, such Stockholder’s Covered Shares, free and clear of any Liens (other than as
created by this Agreement, liens, encumbrances, and restrictions arising by reason of the federal securities laws, and applicable state
“blue sky” and comparable securities laws or the organizational documents of the Company (including, for the purposes hereof,
any agreements between or among stockholders of the Company)). As of the date hereof, other than the Owned Shares set forth below such
Stockholder’s name on such Stockholder’s counterpart signature page to this Agreement, such Stockholder does not own beneficially
or of record any shares of Company Common Stock or Company Preferred Stock (or any securities convertible into shares of Company Common
Stock or Company Preferred Stock) or any interest therein.

 

    2

    

    

 

(b) Such
Stockholder in each case except as provided in this Agreement, the Stockholders Agreement or the Company’s organizational
documents (i) has full voting power, full power of disposition and full power to issue instructions with respect to the matters set
forth herein whether by ownership or by proxy, in each case, with respect to such Stockholder’s Covered Shares, (ii) has not
entered into any voting agreement or voting trust, and has no knowledge and is not aware of any such voting agreement or voting
trust in effect with respect to any of such Stockholder’s Covered Shares that is inconsistent with such Stockholder’s
obligations pursuant to this Agreement, (iii) has not granted a proxy or power of attorney with respect to any of such
Stockholder’s Covered Shares that is inconsistent with such Stockholder’s obligations pursuant to this Agreement, and
has no knowledge and is not aware of any such proxy or power of attorney in effect, and (iv) has not entered into any agreement or
undertaking that is otherwise inconsistent with, or would interfere with, or prohibit or prevent it from satisfying, its obligations
pursuant to this Agreement, and has no knowledge and is not aware of any such agreement or undertaking.

 

(c) Such
Stockholder affirms that (i) if the Stockholder is a natural person, he or she has all the requisite power and authority and has taken
all action necessary in order to execute and deliver this Agreement, to perform his or her obligations hereunder and to consummate the
transaction contemplated hereby, and (ii) if the Stockholder is not a natural person, (A) is a legal entity duly organized, validly existing
and, to the extent such concept is applicable, in good standing under the laws of the jurisdiction of its organization, and (B) has all
requisite corporate or other power and authority and has taken all corporate or other action necessary in order to, execute, deliver
and perform its obligations under this Agreement and to consummate the transactions contemplated hereby. This Agreement has been duly
executed and delivered by such Stockholder and, subject to the due execution and delivery of this Agreement by each other Party hereto,
constitutes a legally valid and binding agreement of such Stockholder enforceable against the Stockholder in accordance with the terms
hereof (except as enforceability may be limited by bankruptcy laws or other similar laws affecting creditors’ rights and general
principles of equity affecting the availability of specific performance and other equitable remedies).

 

(d) Other
than the filings, notices and reports pursuant to, in compliance with or required to be made under the Exchange Act, no filings, notices,
reports, consents, registrations, approvals, permits, waivers, expirations of waiting periods or authorizations are required to be obtained
by such Stockholder from, or to be given by such Stockholder to, or be made by such Stockholder with, any Governmental Authority in connection
with the execution, delivery and performance by such Stockholder of this Agreement, the consummation of the transactions contemplated
hereby or the Merger or the other transactions contemplated by the Business Combination Agreement.

 

(e) The
execution, delivery and performance of this Agreement by such Stockholder does not, and the consummation of the transactions
contemplated hereby and the Merger and the other transactions contemplated by the Business Combination Agreement will not,
constitute or result in (i) a breach or violation of, or a default under, the organizational documents of such Stockholder (if such
Stockholder is not a natural person), (ii) with or without notice, lapse of time or both, a breach or violation of, a termination
(or right of termination) of or a default under, the loss of any benefit under, the creation, modification or acceleration of any
obligations under or the creation of a Lien on any of the properties, rights or assets of such Stockholder pursuant to any contract
binding upon such Stockholder or, assuming (solely with respect to performance of this Agreement and the transactions contemplated
hereby), compliance with the matters referred to in Section 4(d), under any applicable law to which such Stockholder is
subject or (iii) any change in the rights or obligations of any party under any material contract legally binding upon such
Stockholder, except, in the case of clauses (ii) or (iii) directly above, for any such breach, violation, termination,
default, creation, acceleration or change that would not, individually or in the aggregate, reasonably be expected to prevent or
materially delay or impair such Stockholder’s ability to perform its obligations hereunder or to consummate the transactions
contemplated hereby, the consummation of the Merger or the other transactions contemplated by the Business Combination
Agreement.

 

(f) As
of the date of this Agreement, there is no action, proceeding or investigation pending against such Stockholder or, to the knowledge
of such Stockholder, threatened against such Stockholder that, in any manner, questions the beneficial or record ownership of the Stockholder’s
Covered Shares or the validity of this Agreement, or challenges or seeks to prevent, enjoin or materially delay the performance by such
Stockholder of its obligations under this Agreement.

 

(g) The
Stockholder is a sophisticated stockholder and has adequate information concerning the business and financial condition of SPAC and the
Company to make an informed decision regarding this Agreement and the other transactions contemplated by the Business Combination Agreement
and has independently and based on such information as the Stockholder has deemed appropriate, made his/her/its own analysis and decision
to enter into this Agreement. The Stockholder acknowledges that SPAC and the Company have not made and do not make any representation
or warranty, whether express or implied, of any kind or character except as expressly set forth in this Agreement. The Stockholder acknowledges
that the agreements contained herein with respect to the Covered Shares held by the Stockholder are irrevocable.

 

    3

    

    

 

(h) Such
Stockholder understands and acknowledges that SPAC is entering into the Business Combination Agreement in reliance upon such Stockholder’s
execution and delivery of this Agreement and the representations, warranties, covenants and other agreements of such Stockholder contained
herein.

 

(i) No
investment banker, broker, finder or other intermediary is entitled to any broker’s, finder’s, financial advisor’s
or other similar fee or commission for which SPAC or the Company is or could be liable in connection with the Business Combination Agreement
or this Agreement or any of the respective transactions contemplated hereby or thereby, in each case based upon arrangements made by
such Stockholder in his, her or its capacity as a stockholder or, to the knowledge of such Stockholder, on behalf of such Stockholder
in his, her or its capacity as a stockholder.

 

5. Certain
Covenants of the Stockholders. Except in accordance with the terms of this Agreement, each Stockholder hereby covenants and agrees
as follows:

 

(a) No
Solicitation. Subject to Section 6 hereof, prior to the Termination Date, the Stockholder shall not, and, to the extent
applicable, shall cause its affiliates and subsidiaries not to, and shall use its reasonable best efforts to cause its and their
respective Representatives not to, directly or indirectly, (i) initiate, solicit or knowingly encourage or knowingly facilitate any
inquiries or requests for information with respect to, or the making of, any inquiry regarding, or any proposal or offer that
constitutes, or could reasonably be expected to result in or lead to, any Alternative Transaction, (ii) engage in, continue or
otherwise participate in any negotiations or discussions concerning, or provide access to his/her/its properties, books and records
or any confidential information or data to, any person relating to any proposal, offer, inquiry or request for information that
constitutes, or could reasonably be expected to result in or lead to, any Alternative Transaction, (iii) approve, endorse or
recommend, or propose publicly to approve, endorse or recommend, any Alternative Transaction, (iv) execute or enter into, any letter
of intent, memorandum of understanding, agreement in principle, confidentiality agreement, merger agreement, acquisition agreement,
exchange agreement, joint venture agreement, partnership agreement, option agreement or other similar agreement for or relating to
any Alternative Transaction or (v) resolve or agree to do any of the foregoing. Such Stockholder also agrees that immediately
following the execution of this Agreement such Stockholder shall, and, to the extent applicable, shall cause each of its affiliates
and subsidiaries to, and shall use such Stockholder’s reasonable best efforts to cause its and their Representatives to, cease
any solicitations, discussions or negotiations with any person (other than the Parties and their respective Representatives)
conducted heretofore in connection with an Alternative Transaction or any inquiry or request for information that could reasonably
be expected to lead to, or result in, an Alternative Transaction. Such Stockholder shall promptly (and in any event within one
Business Day) notify, in writing, SPAC of the receipt of any inquiry, proposal, offer or request for information received after the
date hereof that constitutes, or could reasonably be expected to result in or lead to, any Company Business Combination, which
notice shall include a summary of the material terms of such inquiry, proposal or offer (and shall include any other documents
evidencing or specifying the terms of such proposal, offer, inquiry or request).

 

Such
Stockholder shall promptly (and in any event within 24 hours) keep SPAC reasonably informed of any material developments with respect
to any such inquiry, proposal, offer, request for information or Alternative Transaction (including any material changes thereto and
copies of any additional written materials received by such Stockholder, the Company, its subsidiaries or their respective affiliates
or Representatives).

 

Notwithstanding
anything in this Agreement to the contrary, (i) such Stockholder shall not be responsible for the actions of the Company or the board
of directors of the Company (or any committee thereof), any subsidiary of the Company, or any officers, directors (in their capacity
as such), employees and professional advisors of any of the foregoing (collectively, the “Company Related Parties”),
(ii) such Stockholder makes no representations or warranties with respect to the actions of any of the Company Related Parties, and (iii)
any breach by the Company of its obligations under Section 7.11 of the Business Combination Agreement shall not be considered a breach
of this Section 5(a) (it being understood that, for the avoidance of doubt, such Stockholder or his, her or its Representatives
(other than any such Representative that is a Company Related Party) shall remain responsible for any breach by such Stockholder or his,
her or its Representatives of this Section 5(a)).

 

    4

    

    

 

(b) Each
Stockholder hereby agrees not to, directly or indirectly, (i) sell, transfer, pledge, encumber, assign, hedge, swap, convert or
otherwise dispose of (including by merger (including by conversion into securities or other consideration), by tendering into any
tender or exchange offer, by testamentary disposition, by operation of Law or otherwise), either voluntarily or involuntarily
(collectively, “Transfer”), or enter into any contract or option with respect to the Transfer of, any of such
Stockholder’s Covered Shares, or (ii) take any action that would make any representation or warranty of such Stockholder
contained herein untrue or incorrect or have the effect of preventing or disabling such Stockholder from performing its obligations
under this Agreement; provided, however, that nothing herein shall prohibit a Transfer to (i) an affiliate of the
Stockholder, (ii) if the undersigned is not a natural person, to its managers, partners, members or other direct or indirect equity
holders or to any of its other affiliates or any subsidiary, employee, officer, director, investment fund controlled or managed by
the undersigned or its affiliates, or commonly controlled or managed investment fund, (iii) to the immediate family members
(including spouses, significant others, lineal descendants, brothers and sisters) of the undersigned, (iv) to a family trust,
foundation or partnership established for the exclusive benefit of the undersigned, its equity holders or any of their respective
immediate family members, or (v) to a charitable foundation controlled by the undersigned, its affiliates, partners, members or
other direct or indirect equityholders or any of their respective immediate family members (each, a “Permitted
Transfer”); provided, further, that any Permitted Transfer shall be permitted only if, as a precondition to
such Transfer, the transferee agrees in a writing, reasonably satisfactory in form and substance to SPAC, to assume all of the
obligations of the Stockholder under, and be bound by all of the terms of, this Agreement; provided, further, that any
Transfer permitted under this Section 5(b) shall not relieve the Stockholder of its obligations under this Agreement. Any
Transfer in violation of this Section 5(b) with respect to the Stockholder’s Covered Shares shall be null and
void.

 

(c) Each
Stockholder hereby authorizes the Company to maintain a copy of this Agreement at either the executive office or the registered office
of the Company.

 

6. Further
Assurances. From time to time, at SPAC’s request and without further consideration, each Stockholder shall execute and deliver
such additional documents and take all such further action as may be reasonably necessary or reasonably requested to effect the actions
and consummate the transactions contemplated by the Business Combination Agreement and this Agreement. Each Stockholder further agrees
not to commence or participate in, and to take all actions necessary to opt out of any class in any class action with respect to, any
action or claim, derivative or otherwise, against SPAC, SPAC’s affiliates, the Sponsor, the Company or any of their respective
successors and assigns relating to the negotiation, execution or delivery of this Agreement, the Business Combination Agreement or the
consummation of the transactions contemplated hereby and thereby, including but not limited to any claims of conflict of interest and
self-dealing.

 

7. Disclosure.
Such Stockholder hereby authorizes the Company and SPAC to publish and disclose in any announcement or disclosure required by the SEC
such Stockholder’s identity and ownership of the Covered Shares and the nature of such Stockholder’s obligations under this
Agreement.

 

8. Changes
in Capital Stock. In the event (i) of a stock split, stock dividend or distribution, or any change in Company Common Stock or
Company Preferred Stock by reason of any split-up, reverse stock split, recapitalization, combination, reclassification, exchange of
shares or the like, (ii) the Stockholder purchases or otherwise acquires beneficial ownership of any Company Common Stock or Company
Preferred Stock or (iii) the Stockholder acquires the right to vote or share in the voting of any Company Common Stock or Company
Preferred Stock, the terms “Owned Shares” and “Covered Shares” shall be deemed to refer to and include such
shares as well as all such stock dividends and distributions and any securities into which or for which any or all of such shares
may be changed or exchanged or which are received in such transaction.

 

9. Amendment
and Modification. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise,
except by an instrument in writing signed by the Company, SPAC and the applicable Stockholder.

 

10. Waiver.
No failure or delay by any Party exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single
or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The
rights and remedies of the Parties hereunder are cumulative and are not exclusive of any rights or remedies which they would otherwise
have hereunder. Any agreement on the part of a Party to any such waiver shall be valid only if set forth in a written instrument executed
and delivered by such party.

 

    5

    

    

 

11. Notices.
All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally, by email (with
confirmation of receipt) or sent by a nationally recognized overnight courier service, such as FedEx, to the Parties at the following
addresses (or at such other address for a party as shall be specified by like notice made pursuant to this Section 11):

 

(a) if
to the Stockholder, to the address or email address set forth below such Stockholder’s name on such Stockholder’s counterpart
signature page to this Agreement, or in the absence of such address or email address being set forth below such Stockholder’s name
on such Stockholder’s counterpart signature page to this Agreement, the address or email address set forth in the Company’s
books and records, or to such other address or email address or to the attention of such other person as such Stockholder has specified
by prior written notice to the sending Party,

 

with
a copy (which shall not constitute notice) to:

 

Lowenstein Sandler LLP

One
Lowenstein Drive

Roseland,
New Jersey 07068
 Attention: Michael Lerner

     Steven Skolnick

Email:       mlerner@lowenstein.com

   sskolnick@lowenstein.com

 

(b) if
to SPAC, to it at:

 

Larkspur
Health Acquisition Corp.

217 W Main St.

Somerville,
NJ 08876

Attention:  Daniel J. O’Connor

    David
Briones

Email:        doconnor@lsprhealth.com

    dbriones@briofinancial.com

 

with
a copy (which shall not constitute notice) to:

 

Alston
& Bird LLP

90 Park Avenue

New
York, NY 10016

Attention:   Matthew W. Mamak

Email:         matthew.mamak@alston.com

 

12. No
Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in SPAC any direct or indirect ownership or incidence
of ownership of or with respect to the Covered Shares of the Stockholder. All rights, ownership and economic benefits of and relating
to the Covered Shares of the Stockholder shall remain vested in and belong to the Stockholder, and SPAC shall have no authority to direct
the Stockholder in the voting or disposition of any of the Stockholder’s Covered Shares, except as otherwise provided herein.

 

13. Entire
Agreement. This Agreement and the Business Combination Agreement constitute the entire agreement and supersede all prior agreements
and understandings, both written and oral, between the Parties with respect to the subject matter hereof and thereof.

 

14. No
Third-Party Beneficiaries. The Stockholder hereby agrees that his/her/its representations, warranties and covenants set forth herein
are solely for the benefit of SPAC in accordance with and subject to the terms of this Agreement, and this Agreement is not intended
to, and does not, confer upon any person other than the Parties any rights or remedies hereunder, including the right to rely upon the
representations and warranties set forth herein, and the Parties hereby further agree that this Agreement may only be enforced against,
and any action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this
Agreement may only be made against, the persons expressly named as parties hereto; provided that the Company shall be an express
third-party beneficiary with respect to Section 4 and Section 5(b).

 

    6

    

    

 

 15. Governing Law and Venue; Service of Process; Waiver of Jury Trial.

 

(a) This
Agreement, and all claims or causes of action based upon, arising out of, or related to this Agreement or the transactions contemplated
hereby, shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to principles
or rules of conflicts of laws to the extent such principles or rules are not mandatorily applicable and would require or permit the application
of the laws of another jurisdiction other than the State of Delaware.

 

(b) In
addition, each of the Parties (i) consents to submit itself, and hereby submits itself, to the personal jurisdiction of the Court of
Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction, any state or federal court located in
the State of Delaware having subject matter jurisdiction, in the event any dispute arises out of this Agreement or any of the
transactions contemplated by this Agreement, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction by
motion or other request for leave from any such court, and agrees not to plead or claim any objection to the laying of venue in any
such court or that any judicial proceeding in any such court has been brought in an inconvenient forum, (iii) agrees that it will
not bring any action relating to this Agreement or any of the transactions contemplated by this Agreement in any court other than
the Court of Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction, any state or federal
court located in the State of Delaware having subject matter jurisdiction, and (iv) consents to service of process being made
through the notice procedures set forth in Section 11.

 

(c) EACH
OF THE PARTIES HEREBY KNOWINGLY, INTENTIONALLY, VOLUNTARILY AND IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION BASED
UPON, ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

16. Assignment;
Successors. Neither this Agreement nor any of the rights, interests or obligations hereunder shall (a) be assigned by any of the
Stockholders in whole or in part (whether by operation of law or otherwise) without the prior written consent of SPAC and the Company
or

(b)
be assigned by SPAC or the Company in whole or in part (whether by operation of law or otherwise) without the prior written consent of
(i) the Company or SPAC, respectively, and (ii) the applicable Stockholder. Any such assignment without such consent shall be null and
void. This Agreement shall be binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors
and permitted assigns.

 

17. Enforcement.
The rights and remedies of the Parties shall be cumulative with and not exclusive of any other remedy conferred hereby. The Parties agree
that irreparable damage would occur and that the Parties would not have any adequate remedy at law in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the Parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to enforce
specifically the terms and provisions of this Agreement, including each Stockholder’s obligations to vote its Covered Shares as
provided in this Agreement, in the Court of Chancery of the State of Delaware or, if under applicable law exclusive jurisdiction over
such matter is vested in the federal courts, any state or federal court located in the State of Delaware, without proof of actual damages
or otherwise (and each Party hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this
being in addition to any other remedy to which they are entitled at law or in equity.

 

18. Severability.
If any term or other provision of this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void,
unenforceable or against its regulatory policy, the remainder of the terms and provisions of this Agreement shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, so long as the economic and legal substance of the transactions
contemplated hereby, taken as a whole, are not affected in a manner materially adverse to any Party. Upon such a determination, the Parties
shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in an
acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent
possible.

 

    7

    

    

 

19. Counterparts.
This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement, it being
understood that each Party need not sign the same counterpart. This Agreement shall become effective when each Party shall have
received a counterpart hereof signed by all of the other Parties. Signatures delivered electronically or by facsimile shall be
deemed to be original signatures.

 

20. Interpretation
and Construction. The words “hereof,” “herein” and “hereunder” and words
of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement.
The descriptive headings used herein are inserted for convenience of reference only and are not intended to be part of or to affect the
meaning or interpretation of this Agreement. References to Sections are to Sections of this Agreement unless otherwise specified. Any
singular term in this Agreement shall be deemed to include the plural, and any plural term the singular. The definitions contained in
this Agreement are applicable to the masculine as well as to the feminine and neuter genders of such term. Whenever the words “include,”
“includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without
limitation,” whether or not they are in fact followed by those words or words of like import. “Writing,” “written”
and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References
to any statute shall be deemed to refer to such statute and to any rules or regulations promulgated thereunder. References to any person
include the successors and permitted assigns of that person. References from or through any date mean, unless otherwise specified, from
and including such date or through and including such date, respectively. In the event an ambiguity or question of intent or interpretation
arises, this Agreement will be construed as if drafted jointly by the Parties, and no presumption or burden of proof will arise favoring
or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement.

 

21. Capacity
as a Stockholder or Proxy Holder. Notwithstanding anything herein to the contrary, the Stockholder or proxy holder signs this Agreement
solely in the Stockholder’s or proxy holder’s capacity as a stockholder or proxy holder of the Company, and not in any other
capacity and this Agreement shall not limit or otherwise affect the actions of the Stockholder, proxy holder or any affiliate, employee
or designee of the Stockholder or proxy holder, or any of their respective affiliates in his or her capacity, if applicable, as an officer
or director of the Company (or any Subsidiary of the Company) or any other Person, including in the exercise of his or her fiduciary
duties as a director or officer of the Company or any Subsidiary of the Company. No Stockholder shall be liable or responsible for any
breach, default, or violation of any representation, warranty, covenant or agreement by any other Stockholder that is also a Party hereto
and each Stockholder shall solely be required to perform its obligations hereunder in its individual capacity.

 

[The
remainder of this page is intentionally left blank.]

 

 

 

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]